Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
For mentors (people who have been through breast cancer treatment and would support others):
- Adults aged 18 or older
- People who identify as Korean
- People who can read, write, and speak both Korean and English
- People who were diagnosed with breast cancer at least 2 years before joining the trial
- People who have finished active treatment, or who are currently on long-term ongoing therapy
- People who have access to a smartphone, computer, or similar device that works with the study's platform
- People who are willing to take part for at least 3 months
- People who are willing to complete required training and surveys
For mentees (people currently going through breast cancer treatment who would receive support):
- Adults aged 18 or older
- People who identify as Korean
- People who can read, write, and speak Korean
- People who have been diagnosed with breast cancer
- People who are currently receiving treatment, such as chemotherapy, radiation therapy, recent surgery, or hormone therapy
- People who have access to a smartphone, computer, or similar device that works with the study's platform
- People who are willing to take part for at least 3 months
- People who are willing to complete required surveys
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who do not meet the inclusion criteria listed above
- People who are unable to use the online platform or the technology required for the study
- People who the trial investigators determine may not be able to follow through with the study procedures
- Mentees whose breast cancer diagnosis was ductal carcinoma in situ (DCIS), which is a very early, non-invasive form of breast cancer (confirm with trial site if unsure how this applies)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 424-315-0709
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of peer-support platform engagement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.